Tus-Holdings Co., Ltd. entered into an agreement to acquire 22.04% stake in BIOREM Inc. (TSXV:BRM) from Expansion Capital Fund I, L.P. and Clean Technology Fund II, L.P., funds of Expansion Capital Partners, LLC for CAD 1.2 million on June 24, 2016. Tus-Holdings Co will acquire the shares at CAD 0.345 per share. The sale is subject to certain closing conditions including any approvals required from the TSX Venture Exchange, the resignation of Bernardo Llovera from the Board of Directors of Biorem, the expansion of the Board of Directors to five members and the appointment of 2 Directors nominated by TUS to the Board. Biorem has made an application to TSX Venture Exchange for confirmation that the only approval required from the TSX Venture Exchange in respect of the transaction is the approval of TUS as a new insider of Biorem. Tus-Holdings Co., Ltd. completed the acquisition of 22.04% stake in BIOREM Inc. (TSXV:BRM) from Expansion Capital Fund I, L.P. and Clean Technology Fund II, L.P., funds of Expansion Capital Partners, LLC on January 19, 2017. As of January 18, 2017, Sandy Ding and Qing Zhao of Tus Holdings Group have been appointed as Directors of the BIOREM. In connection with the closing, Tus-Holdings has converted the convertible debentures which it acquired and exercised the share purchase warrants which it acquired resulting in Tus-Holdings owning 23.4 million common shares of Biorem or approximately 65.6% of the total issued and outstanding Biorem common shares.